Video
"User-friendly" Levodopa, Advancing Treatment, and Teaching Parkinson's Disease
Author(s):
Norika Malhado-Chang, MD, assistant professor of Neurology at University of California at Davis, discusses how progress in Parkinson's disease and movement disorders is changing the scope of comprehensive care, addressing non-motor symptoms, and supplying tools for the next generation of neurology specialists.
Norika Malhado-Chang, MD, teaches clinical neurology for 3rd- and 4th-year medical students at the University of California at Davis. That responsibility on the assistant professor of Neurology compounds when one considers the great changes of perspective, product, and procedure that have come into the fields of Parkinson's diseas and movement disorders as of late.
At the 21st International Congress of Parkinson's Disease and Movement Disorders in Vancouver, BC, Malhado-Chang discussed advocacy for comprehensive care, improving the safety and efficacy of treatment staple levodopa, and helping shape the future generation of Parkinson's disease specialists.
Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA
